HOME ·

515120.SH

GF CSI Innovative Drugs Industry ETF (515120) Rises 3.42% in Early Trading; Institutions: Leading Pharmaceutical Companies Have Successfully Navigated Centralized Procurement Cycle, Entering Innovation Harvest Period
Tags：
ETF515120.SHGF CSI Innovative Drugs Industry ETF
2026-04-01
BD Transaction Volume Exceeds $60 Billion in First Three Months; GF CSI Innovative Drugs Industry ETF (515120) Rises 1.63% in Early Trading, Targeting Third Consecutive Gain
Tags：
ETF515120.SHGF CSI Innovative Drugs Industry ETF
2026-03-31
GF CSI Innovative Drugs Industry ETF (515120) Rises 0.49% Against Market Trend; Multiple Biomedical Companies Post Strong Earnings Performance
Tags：
ETF515120.SHGF CSI Innovative Drugs Industry ETF
2026-03-30
GF CSI Innovative Drugs Industry ETF (515120) Rises 1.83% in Early Trading; Domestic Innovative Drug BD Amount Reaches $53.276 Billion in First Two Months
Tags：
ETF515120.SHInnovative Medicine ETF
2026-03-17
GF CSI Innovative Drugs Industry ETF(515120) Rises 2.74% Intraday,Institutions Say the Sector’s Fundamentals Remain Sound
Tags：
ETFGF CSI Innovative Drugs Industry ETF515120.SH
2026-03-06
Domestic Innovation Drugs Strengthen Global Competitiveness, GF CSI Innovative Drugs Industry ETF (515120) Up 0.30% in Morning Trading
Tags：
Innovation Drug ETFETF515120.SH
2026-01-09
GF CSI Innovative Drugs Industry ETF (515120) Rises Over 1% in Morning Trading, Aiming for Third Consecutive Gain
Tags：
Innovation Drug ETF515120.SHETF
2026-01-07